I. Vachier (Montpellier, France), S. Dahlén (Stockholm, Sweden)
LSC - 2017 - IL-1R1 but not IL-18Rbeta or IL-18BP contribute to the beneficial effects of IL-37 on experimental asthma M. Wegmann (Borstel, Germany)
| |
LSC - 2017 - Evaluation the effect of bronchoconstriction on airway epithelial cells responses in asthma M. Quesada Del Bosque (Southampton, United Kingdom)
| |
Allergen immunotherapy modulates pro- and antioxidant status patients with bronchial asthma L. Lazarenko (ST PETERSBURG, Russian Federation)
| |
Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry B. Hutyrova (Olomouc, Czech Republic)
| |
Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. J. Stril (Dorval, QC, Canada)
| |
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis J. Cho (Seoul, Republic of Korea)
| |
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD J. Kwon (Chuncheon-Si, Gangwon-Do, Republic of Korea)
| |
AUSTRI and VESTRI LABA Safety studies subgroup analysis of asthma exacerbations and SAEs comparing FSC and FP by ICS dose I. Raphiou (RTP, United States of America)
| |
Dampness at home and asthma in schoolchildren V. Micevska (Skopje, FYROM (Macedonia))
| |
Occurrence of depression in asthmatics and its impact on asthma control and quality of life. S. Batra (DELHI (NEW DELHI), India)
| |
Factors influencing on influenza vaccination among south korean adult asthma : a nationwide population-based cross-section study C. Han (Koyang, Republic of Korea)
| |
Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial P. Hellings (Leuven, Belgium)
| |
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis S. Weinstein (Hunitngton Beach, United States of America)
| |
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis A. Khan (Chilly Mazarin Cedex, France)
| |
IL-4/13-induced up-regulation of METEORIN-LIKE (ML) in alveolar macrophages promotes epithelial CCR3 expression X. Yao (Nanjing, Jiangsu, China)
| |
Characterization of CD4-endotypes in severe allergic asthma for future precision medicine G. Ulrich-Merzenich (Bonn, Germany)
| |
Endotoxin exposure increases LL-37, but not calprotectin, in healthy human airways M. Smith (Gothenburg, Sweden)
| |
Risks for asthma exacerbations in patients with type 2-low endotype Y. Ishiyama (Kyoto, Japan)
| |